These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26226355)

  • 41. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status.
    Ahrens B; Schulz G; Bellach J; Niggemann B; Beyer K
    Pediatr Allergy Immunol; 2015 Nov; 26(7):634-40. PubMed ID: 26102348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
    Gu CY; Gu L; Dou X
    Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. (+)-Nootkatone inhibits tumor necrosis factor α/interferon γ-induced production of chemokines in HaCaT cells.
    Choi HJ; Lee JH; Jung YS
    Biochem Biophys Res Commun; 2014 May; 447(2):278-84. PubMed ID: 24704449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
    Vestergaard C; Deleuran M; Gesser B; Larsen CG
    Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS).
    Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J
    Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
    Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
    J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atopic Dermatitis: Striving for Reliable Biomarkers.
    Mastraftsi S; Vrioni G; Bakakis M; Nicolaidou E; Rigopoulos D; Stratigos AJ; Gregoriou S
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
    Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
    J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic idiopathic erythroderma of elderly men is an independent entity that has a distinct TARC/IgE profile from adult atopic dermatitis.
    Ohga Y; Bayaraa B; Imafuku S
    Int J Dermatol; 2018 Jun; 57(6):670-674. PubMed ID: 29590497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria.
    Lu T; Jiao X; Si M; He P; Zou J; Zhang S; Zeng K
    Dis Markers; 2016; 2016():1381760. PubMed ID: 27057079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential biomarkers of atopic dermatitis.
    Yu L; Li L
    Front Med (Lausanne); 2022; 9():1028694. PubMed ID: 36465933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
    Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-κB activation.
    Osabe M; Tajika T; Tohkin M
    J Appl Toxicol; 2018 Feb; 38(2):274-283. PubMed ID: 28949055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
    Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [TARC (thymus and activation regulated chemokine)].
    Nakamura K
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():41-5. PubMed ID: 20941997
    [No Abstract]   [Full Text] [Related]  

  • 56. EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
    Thijs JL; Drylewicz J; Fiechter R; Strickland I; Sleeman MA; Herath A; May RD; Bruijnzeel-Koomen CAFM; Knol EF; Giovannone B; de Bruin-Weller MS; Nierkens S; Hijnen DJ
    J Allergy Clin Immunol; 2017 Dec; 140(6):1703-1705. PubMed ID: 28823810
    [No Abstract]   [Full Text] [Related]  

  • 57. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments.
    Yasukochi Y; Nakahara T; Abe T; Kido-Nakahara M; Kohda F; Takeuchi S; Hagihara A; Furue M
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):240-5. PubMed ID: 25268342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis.
    Riis JL; Johansen C; Vestergaard C; Bech R; Kragballe K; Iversen L
    Exp Dermatol; 2011 Oct; 20(10):789-94. PubMed ID: 21707761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2015 - FORCUSING ON THE BIOMARKER AND SKIN CARE].
    Katoh N
    Arerugi; 2017; 66(8):991-994. PubMed ID: 28904286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.